DC
JAZZ icon

Deere & Company’s Jazz Pharmaceuticals JAZZ Stock Holding History

Deere & Company’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-8,340
Closed -$1.18M – 1061
2016
Q2 		$1.18M Sell
8,340
-5,931
-42% -$874K 0.06% 331
2016
Q1 		$1.86M Buy
14,271
+2,419
+20% +$301K 0.1% 220
2015
Q4 		$1.67M Buy
11,852
+2,171
+22% +$301K 0.1% 247
2015
Q3 		$1.29M Hold
9,681
– – 0.08% 283
2015
Q2 		$1.71M Sell
9,681
-1,161
-11% -$209K 0.09% 269
2015
Q1 		$1.87M Buy
10,842
+1,207
+13% +$207K 0.1% 240
2014
Q4 		$1.58M Buy
9,635
+1,405
+17% +$233K 0.09% 278
2014
Q3 		$1.32M Sell
8,230
-2,438
-23% -$375K 0.07% 290
2014
Q2 		$1.57M Buy
10,668
+30
+0.3% +$4.16K 0.09% 264
2014
Q1 		$1.48M Buy
+10,638
New +$1.6M 0.08% 276
2013
Q4 		– Sell
-3,193
Closed -$294K – 1025
2013
Q3 		$294K Hold
3,193
– – 0.02% 768
2013
Q2 		$219K Buy
+3,193
New +$195K 0.01% 819

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deere & Company's JAZZ Position: Q3 2016 in Review

Deere & Company sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2016, closing a stake of 8,340 shares — an estimated $1.18M sold.

Deere & Company first reported a position in JAZZ in Q2 2013 and held it in 12 quarters. The position peaked at $1.87M in Q1 2015. 325 funds tracked by Wall St. Rank hold JAZZ as of Q3 2016.

  • Deere & Company reported no remaining Jazz Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Deere & Company sold 8,340 Jazz Pharmaceuticals shares in Q3 2016, an estimated $1.18M.
  • Deere & Company first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 12 quarters.
  • Deere & Company's Jazz Pharmaceuticals position peaked at $1.87M in Q1 2015.
  • 325 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2016.

Based on Deere & Company's 13F filing for Q3 2016, filed 14 Nov 2016.